United States · FDA National Drug Code directory
Atazanavir Sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-711_8f8c56e0-40ee-4643-88f7-d3571ff5a409
- Product NDC
- 65862-711
- Form
- CAPSULE
- Composition / generic term
- Atazanavir
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180625
- Source listing expiry
- 20261231
Source-listed ingredients
- ATAZANAVIR SULFATE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (65862-711-03) / 10 CAPSULE in 1 BLISTER PACK (65862-711-10) · 65862-711-03
- 500 CAPSULE in 1 BOTTLE (65862-711-05) · 65862-711-05
- 180 CAPSULE in 1 BOTTLE (65862-711-18) · 65862-711-18
- 60 CAPSULE in 1 BOTTLE (65862-711-60) · 65862-711-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →